Table 1 Clinicopathologic characteristics
Age at diagnosis (years), median, z (range) | 74 (26–93) |
Stage (FIGO) | |
I | 44 (47%) |
II | 9 (10%) |
III | 40 (43%) |
Tumor size (mm), median, (range) | 30 (1–110) |
Lymph nodes metastases | |
Positive | 38 (41%) |
Negative | 55 (59%) |
Lymph node metastases size (mm), median, (range) | 8.5 (0.4–39) |
Primary treatment | |
Surgery | 43 (46%) |
Surgery + radiotherapy | 42 (45%) |
Chemotherapy + radiotherapy | 7 (8%) |
Surgery + radiotherapy + chemotherapy | 1 (1%) |
Surgical margins | |
Positive | 7 (8%) |
Negative | 84 (92%) |
Recurrent disease | |
Local recurrence/lymph node metastases | 27 (29%)/17 (18%) |
Distant recurrence | 2 (2%) |
Follow-up data | |
Died of disease | 35 (38%) |
